Key oncologic pathways inhibited by Erinacine A: A perspective for its development as an anticancer molecule

Biochemistry, Genetics and Molecular Biology

• Anticancer 100%
• Programmed Cell Death 50%
• Cancer Cell 50%
• Oxidative Stress 50%
• Antineoplastic Activity 50%
• Cell Cycle Arrest 50%
• Cell Cycle Checkpoint 50%
• Metabolite 50%
• In Vivo Study 50%
• Hericium erinaceus 50%
• Basidiomycete 50%

Medicine and Dentistry

• Cell Signaling Pathway 100%
• Malignant Neoplasm 66%
• In Vitro 33%
• Diseases 33%
• Programmed Cell Death 33%
• Cancer Cell 33%
• Metabolite 33%
• Oxidative Stress 33%
• Antineoplastic Activity 33%
• Adjuvant Therapy 33%
• Cell Cycle Checkpoint 33%
• Chemotherapy 33%
• Cell Cycle Arrest 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Diseases 33%
• Chemotherapy 33%
• Basidiomycete 33%
• Hericium erinaceus 33%